Blog From Niche to Necessity: Precision Medicine Isn’t an Initiative. It’s the New Infrastructure.By James Lu, MD, PhD, CEO and Co-Founder of Helix
Press ReleasesHelix Announces Multi-Year Agreement with Alnylam to Drive Precision Medicine DevelopmentMarch 5, 2026
Press ReleasesHelix Partners with Mawi DNA Technologies to Expand Access to Non-Invasive Genomic Sample CollectionFebruary 10, 2026
Press ReleasesHelix Announces Multi-Year Strategic Collaboration with GSK to Drive Precision Medicine DevelopmentJanuary 7, 2026
VideosPartner Perspectives with Nebraska MedicineGenetic Insights Project helps Nebraskans take charge of their health
1Published ResearchPopulation Genomic Screening Improves Lipid Management in Familial HypercholesterolemiaNovember 6, 2025
2Published ResearchPopulation Genomic Screening and Improved Lipid Management in Patients With Familial HypercholesterolemiaNovember 5, 2025
3Published ResearchFrom Uncertain to Actionable: Significant Reduction in Variants of Uncertain Significance in Hereditary Germline Testing via Multi-Institutional Real-World EvidenceAugust 15, 2025
4Published ResearchNovel Method for Predicting Lp(a) From Genomic Testing Identifies ASCVD Risk Across a Diverse CohortJuly 30, 2025
5Published ResearchChatbot for the Return of Positive Genetic Screening Results for Hereditary Cancer Syndromes: Prompt Engineering ProjectJune 10, 2025
Press ReleasesApr 27, 2022Study Shows Importance of Ensuring Participant and Provider Follow-up After a Genetic Screening Result
Blog Apr 21, 2022Three Strategies to Reduce Documentation Burden While Implementing Population Health Programs at Your Health System
ResearchApr 14, 2022HLA-A∗03:01 is associated with increased risk of fever, chills, and stronger side effects from Pfizer-BioNTech COVID-19 vaccinationHGG ADVANCES
NewsApr 7, 2022How population genomics is changing clinical care at health systems - 4 takeawaysBeckers
NewsApr 6, 2022HealthPartners seeks 100,000 volunteers to participate in DNA testing programNBC KARE11
Blog From Niche to Necessity: Precision Medicine Isn’t an Initiative. It’s the New Infrastructure.By James Lu, MD, PhD, CEO and Co-Founder of Helix
Press ReleasesHelix Announces Multi-Year Agreement with Alnylam to Drive Precision Medicine DevelopmentMarch 5, 2026
Press ReleasesHelix Partners with Mawi DNA Technologies to Expand Access to Non-Invasive Genomic Sample CollectionFebruary 10, 2026
Press ReleasesHelix Announces Multi-Year Strategic Collaboration with GSK to Drive Precision Medicine DevelopmentJanuary 7, 2026
VideosPartner Perspectives with Nebraska MedicineGenetic Insights Project helps Nebraskans take charge of their health
1Published ResearchPopulation Genomic Screening Improves Lipid Management in Familial HypercholesterolemiaNovember 6, 2025
2Published ResearchPopulation Genomic Screening and Improved Lipid Management in Patients With Familial HypercholesterolemiaNovember 5, 2025
3Published ResearchFrom Uncertain to Actionable: Significant Reduction in Variants of Uncertain Significance in Hereditary Germline Testing via Multi-Institutional Real-World EvidenceAugust 15, 2025
4Published ResearchNovel Method for Predicting Lp(a) From Genomic Testing Identifies ASCVD Risk Across a Diverse CohortJuly 30, 2025
5Published ResearchChatbot for the Return of Positive Genetic Screening Results for Hereditary Cancer Syndromes: Prompt Engineering ProjectJune 10, 2025